0 NYSE Companies - January 25, 2024Northrop Grumman Releases Fourth Quarter and Full-Year 2023 Financial ResultsFALLS CHURCH, Va., Jan. 25, 2024 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) has released its fourth quarter and […]Read More
0 NYSE Companies - January 25, 2024TopBuild to Release Fourth Quarter 2023 Results Wednesday, February 28DAYTONA BEACH, Fla., Jan. 25, 2024 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation […]Read More
0 NASDAQ Companies - January 25, 2024Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 MillionFLORHAM PARK, N.J., Jan. 25, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused […]Read More
0 NASDAQ Companies - January 25, 2024CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research CollaborationCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 (GLOBE NEWSWIRE) — CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the […]Read More
0 NASDAQ Companies - January 25, 2024Vera Therapeutics Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy– Participants treated with atacicept for 72 weeks showed consistent and sustained reductions in Gd-IgA1, hematuria, and UPCR, with stable […]Read More
0 NASDAQ Companies - January 25, 2024eGain to Announce Fiscal 2024 Second Quarter Financial Results on February 8, 2024SUNNYVALE, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), a knowledge automation platform for customer engagement, will announce its […]Read More
0 NYSE Companies - January 25, 2024Parsons Wins Contract for Department of Labor Facilities ManagementCHANTILLY, Va., Jan. 25, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company was selected by […]Read More
0 NASDAQ Companies - January 25, 2024Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powderMORRISVILLE, N.C., Jan. 25, 2024 (GLOBE NEWSWIRE) — Liquidia Corporation (the Company) (NASDAQ: LQDA) announced today that the U.S. Food […]Read More
0 NASDAQ Companies - January 25, 2024Virtu Announces Fourth Quarter 2023 ResultsNEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (NASDAQ: VIRT), a leading provider of financial services and […]Read More
0 NYSE Companies - January 25, 2024Macerich to Welcome Life Time to Twenty Ninth Street in BoulderSANTA MONICA, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) — Macerich (NYSE: MAC), one of the nation’s leading owners, operators and […]Read More